{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:06:29Z","timestamp":1793048789670,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.iac.2014.01.003","type":"journal-article","created":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T13:47:46Z","timestamp":1397742466000},"page":"283-295","source":"Crossref","is-referenced-by-count":181,"title":["Epidemiology, Prognosis, and Risk Factors in Mastocytosis"],"prefix":"10.1016","volume":"34","author":[{"given":"Knut","family":"Brockow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2014.01.003_bib1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(96)07056-0","article-title":"Mastocytosis","volume":"349","author":"Golkar","year":"1997","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.iac.2014.01.003_bib2","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2014.01.003_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.iac.2014.01.003_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.iac.2014.01.003_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00508-012-0293-z","article-title":"European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives","volume":"124","author":"Valent","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.iac.2014.01.003_bib6","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","article-title":"Prevalence of indolent systemic mastocytosis in a Dutch region","volume":"131","author":"van Doormaal","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000315946","article-title":"Mastocytosis","volume":"95","author":"Brockow","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.iac.2014.01.003_bib8","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1111\/1523-1747.ep12468942","article-title":"Pediatric mastocytosis","volume":"96","author":"Kettelhut","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2014.01.003_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1046\/j.1365-2141.1999.01683.x","article-title":"C-kit activating mutation in a neonate with in-utero presentation of systemic mastocytosis associated with myeloproliferative disorder","volume":"106","author":"Kuint","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2014.01.003_bib10","series-title":"Clinical immunology. Vol. 1","article-title":"Mastocytosis","author":"Brockow","year":"2001"},{"key":"10.1016\/j.iac.2014.01.003_bib11","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2014.01.003_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3324\/haematol.2010.034553","article-title":"Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis","volume":"96","author":"Zanotti","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.iac.2014.01.003_bib13","doi-asserted-by":"crossref","unstructured":"Alvarez-Twose I, Zanotti R, Gonzalez-de-Olano D, et al. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM. J Allergy Clin Immunol. pii: S0091-6749(13)00988-3. http:\/\/dx.doi.org\/10.1016\/j.jaci.2013.06.020. Accessed August 3, 2013. [Epub ahead of print].","DOI":"10.1016\/j.jaci.2013.06.020"},{"key":"10.1016\/j.iac.2014.01.003_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000096442","article-title":"Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome","volume":"142","author":"Sonneck","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib15","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.003_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","article-title":"Mast cell activation syndrome: a newly\u00a0recognized disorder with systemic clinical manifestations","volume":"128","author":"Hamilton","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib20","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1111\/1523-1747.ep12469034","article-title":"Hematologic aspects of mastocytosis: I: bone marrow pathology in adult and pediatric systemic mast cell disease","volume":"96","author":"Parker","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2014.01.003_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0190-9622(88)70007-9","article-title":"Bone marrow findings in adult patients with urticaria pigmentosa","volume":"18","author":"Czarnetzki","year":"1988","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2014.01.003_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ajcp\/109.3.279","article-title":"Urticaria pigmentosa: a clinical, hematopathologic, and serologic study of 30 adults","volume":"109","author":"Topar","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.iac.2014.01.003_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11882-011-0199-2","article-title":"Update on diagnosis and treatment of mastocytosis","volume":"11","author":"Brockow","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.iac.2014.01.003_bib24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ajcp\/91.5.558","article-title":"Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients","volume":"91","author":"Kettelhut","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.iac.2014.01.003_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.22125","article-title":"Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology","volume":"53","author":"Uzzaman","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.iac.2014.01.003_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1213\/ane.0b013e31817e6d7c","article-title":"Pediatric mastocytosis: routine anesthetic management for a complex disease","volume":"107","author":"Carter","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.iac.2014.01.003_bib28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1182\/blood-2010-05-285270","article-title":"The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)","volume":"116","author":"Valent","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.003_bib29","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.iac.2014.01.003_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00277-013-1964-1","article-title":"The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis","volume":"93","author":"Erben","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.iac.2014.01.003_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MPH.0b013e318279e392","article-title":"Mast cell sarcoma in an infant: a case report and review of the literature","volume":"35","author":"Bautista-Quach","year":"2013","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.iac.2014.01.003_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1067\/mjd.2003.98","article-title":"Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology","volume":"48","author":"Brockow","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2014.01.003_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.iac.2004.01.002","article-title":"Urticaria pigmentosa","volume":"24","author":"Brockow","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.iac.2014.01.003_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1440-0960.2001.00466.x","article-title":"Presentation of cutaneous mastocytosis in 173 children","volume":"42","author":"Hannaford","year":"2001","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.iac.2014.01.003_bib35","first-page":"96","article-title":"Telangiectasia macularis eruptiva perstans: probably a telangiectatic variety of urticaria pigmentosa in an adult","volume":"24","author":"Weber","year":"1930","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.iac.2014.01.003_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archderm.1951.01570020066009","article-title":"Telangiectasia macularis eruptiva perstans: review of the literature, report of a case and discussion of the etiology and pathology of generalized telangiectasia","volume":"63","author":"Moursund","year":"1951","journal-title":"AMA Arch Derm Syphilol"},{"key":"10.1016\/j.iac.2014.01.003_bib37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archderm.138.6.785","article-title":"Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease","volume":"138","author":"Brockow","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.iac.2014.01.003_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","article-title":"Systemic mast cell disease. Analysis of 58\u00a0cases and literature review","volume":"67","author":"Travis","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.iac.2014.01.003_bib39","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.4065\/77.11.1169","article-title":"Systemic mast cell disease without associated hematologic disorder: a combined retrospective and prospective study","volume":"77","author":"Pardanani","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.iac.2014.01.003_bib40","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.21561","article-title":"Cytoreductive therapy in 108 adults with systemic mastocytosis: outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine","volume":"84","author":"Lim","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.iac.2014.01.003_bib41","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/leu.2013.11","article-title":"Increased circulating IL-2Ralpha (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype study","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.iac.2014.01.003_bib42","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2011.293","article-title":"An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis","volume":"26","author":"Teodosio","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.iac.2014.01.003_bib43","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis","volume":"122","author":"Schwaab","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.003_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1525-1470.2000.01751.x","article-title":"Diffuse cutaneous mastocytosis with bone marrow infiltration in a child: a case report","volume":"17","author":"Waxtein","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.iac.2014.01.003_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","article-title":"Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis","volume":"67","author":"Alvarez-Twose","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2014.01.003_bib46","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/all.12013","article-title":"Extensive blistering is a predictor for severe complications in children with mastocytosis","volume":"67","author":"Brockow","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2014.01.003_bib47","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1525-1470.1999.00116.x","article-title":"Bullous mastocytosis: a fatal outcome","volume":"16","author":"Murphy","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.iac.2014.01.003_bib48","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1525-1470.1984.tb01131.x","article-title":"Bullous mastocytosis: diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme","volume":"1","author":"Golitz","year":"1984","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2014.01.003_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/modpathol.2013.117","article-title":"Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis","volume":"27","author":"Berezowska","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.iac.2014.01.003_bib50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.iac.2014.01.003_bib51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1398-9995.2012.02809.x","article-title":"Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions","volume":"67","author":"van Doormaal","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2014.01.003_bib52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/ejh.12128","article-title":"Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis","volume":"91","author":"Kristensen","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.iac.2014.01.003_bib53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaci.2013.02.019","article-title":"KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis","volume":"132","author":"Broesby-Olsen","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib54","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V96.4.1267","article-title":"Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology","volume":"96","author":"Akin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.003_bib55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clim.2005.01.011","article-title":"IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis","volume":"115","author":"Brockow","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2014.01.003_bib57","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonzalez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2014.01.003_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis: a single-center experience","volume":"44","author":"Gulen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2014.01.003_bib59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(00)03647-3","article-title":"Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings","volume":"357","author":"Ludolph-Hauser","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2014.01.003_bib60","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase. A study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2012.12.1578","article-title":"Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis","volume":"132","author":"van Anrooij","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2014.01.003_bib62","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1398-9995.2009.02108.x","article-title":"How much specific is the association between Hymenoptera venom allergy and mastocytosis?","volume":"64","author":"Bonadonna","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2014.01.003_bib63","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/ACI.0b013e328355b7cb","article-title":"Drug allergy in mast cell disease","volume":"12","author":"Brockow","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2014.01.003_bib64","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/ard.2009.124511","article-title":"Systemic mastocytosis and bone involvement in a cohort of 75 patients","volume":"69","author":"Barete","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.iac.2014.01.003_bib65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1398-9995.2011.02780.x","article-title":"High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis","volume":"67","author":"van der Veer","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2014.01.003_bib66","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","article-title":"Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis","volume":"49","author":"Rossini","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.iac.2014.01.003_bib67","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000091172","article-title":"Elevated tryptase levels are associated with greater bone density in a cohort of patients with mastocytosis","volume":"139","author":"Kushnir-Sukhov","year":"2006","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856114000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856114000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T19:53:58Z","timestamp":1716666838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856114000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0889856114000046"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2014.01.003","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}